Home
>
US Stocks
>
Atreca Inc - Class A
Atreca Inc - Class A
BCEL

Atreca Inc - Class A

$5.199.58%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
5.36
Today Low/High
5.11 / 5.36
52 Week Low/High
$4.8 / $20.29
Market Cap
$177.45M

Company Details

Atreca is a biopharmaceutical company developing novel antibody-based immunotherapeutics generated by its differentiated discovery platform. Atreca's platform allows access to an unexplored landscape in oncology through the identification of unique antibody-target pairs generated by the human immune system during an active immune response against tumors. These antibodies provide the basis for first-in-class therapeutic candidates, such as its lead product candidate ATRC-101. A Phase 1b study evaluating ATRC-101 in multiple solid tumor cancers is currently enrolling patients.
Organisation
Atreca Inc - Class A
Headquaters
South San Francisco, California, US
Employees
130
Industry
Miscellaneous Commercial Services
CEO
John Orwin

Discover more

Frequently Asked Questions

What is Atreca Inc - Class A share price today

Can Indians buy Atreca Inc - Class A shares?

How can I buy Atreca Inc - Class A shares from India?

Can Fractional shares of Atreca Inc - Class A be purchased?

What are the documents required to start investing in Atreca Inc - Class A stocks?

We are a SEBI registered investement advisor